Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019 von Ganesh, Ravindra, Philpot, Lindsey M, Bierle, Dennis M, Anderson, Ryan J, Arndt, Lori L, Arndt, Richard F, Culbertson, Tracy L, Destro Borgen, Molly J, Hanson, Sara N, Kennedy, Brian D, Kottke, Brian B, Larsen, Jennifer J, Ramar, Priya, Rosedahl, Jordan K, Seville, Maria Teresa, Speicher, Leigh L, Tulledge-Scheitel, Sidna M, Wilker, Caroline G, Razonable, Raymund R

Volltext

Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 von Ganesh, Ravindra, Pawlowski, Colin F., O'Horo, John C., Arndt, Lori L., Arndt, Richard F., Bell, Sarah J., Bierle, Dennis M., Borgen, Molly Destro, Hanson, Sara N., Heyliger, Alexander, Larsen, Jennifer J., Lenehan, Patrick J., Orenstein, Robert, Puranik, Arjun, Speicher, Leigh L., Tulledge-Scheitel, Sidna M., Venkatakrishnan, A. J., Wilker, Caroline G., Badley, Andrew D., Razonable, Raymund R.

Volltext

Effectiveness of Monoclonal Antibodies in Preventing Severe COVID-19 With Emergence of the Delta Variant von O’Horo, John C., Challener, Douglas W., Speicher, Leigh, Bosch, Wendelyn, Seville, Maria Teresa, Bierle, Dennis M., Ganesh, Ravindra, Wilker, Caroline G., Arndt, Richard F., Arndt, Lori L., Tulledge-Scheitel, Sidna M., Hanson, Sara N., Razonable, Raymund R.

Volltext

Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coron... von Razonable, Raymund R, O’Horo, John C, Hanson, Sara N, Arndt, Richard F, Speicher, Leigh L, Seville, Teresa A, Hall, Scott T, Pike, Marsha L, Heyliger, Alexander, Larsen, Jennifer J, Ganesh, Ravindra, Tulledge-Scheitel, Sidna M

Volltext

Curbing the Delta Surge: Clinical Outcomes After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Disease 2019 von Razonable, Raymund R, O'Horo, John C, Challener, Douglas W, Arndt, Lori, Arndt, Richard F, Clune, Caroline G, Culbertson, Tracy L, Hall, Scott T, Heyliger, Alexander, Jackson, Tammy A, Kennedy, Brian D, Larsen, Jennifer, Hanson, Sara N, Sweeten, Perry W, Tulledge-Scheitel, Sidna M, Ganesh, Ravindra

Volltext

Pharmacist Impact on Ischemic Stroke Care in the Emergency Department von Gosser, Rena A., PharmD, Arndt, Richard F., PharmD, Schaafsma, Kate, PharmD, MBA, Dang, Cathyyen H., PharmD

Volltext

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019 von O’Horo, John, Challener, Douglas W., Anderson, Ryan J., Arndt, Richard F., Ausman, Sara E., Hall, Scott T., Heyliger, Alexander, Kennedy, Brian D., Sweeten, Perry W., Ganesh, Ravindra, Razonable, Raymund R.

Volltext

Clinical outcomes of COVID‐19 treated with remdesivir across the continuum of care von Rivera, Christina G., Chesdachai, Supavit, Draper, Evan W., Arndt, Richard F., Mara, Kristin C., Gonzalez Suarez, Maria, Razonable, Raymund R.

Volltext

Real-world Clinical Outcomes of Bebtelovimab and Sotrovimab Treatment of High-risk Persons With Coronavirus Disease 2019 During the Omicron Epoch von Razonable, Raymund R, Tulledge-Scheitel, Sidna M, Hanson, Sara N, Arndt, Richard F, Speicher, Leigh L, Seville, Teresa A, Larsen, Jennifer J, Ganesh, Ravindra, O’Horo, John C

Volltext

Engagement of hospital pharmacists and technicians to optimize staffing schedules von Wright, Jessica, Arndt, Richard, Christensen, Jason, Kooda, Kirstin, Cunningham, Julie

Volltext

Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19 von Razonable, Raymund R., Pawlowski, Colin, O'Horo, John C., Arndt, Lori L., Arndt, Richard, Bierle, Dennis M., Borgen, Molly Destro, Hanson, Sara N., Hedin, Michelle C., Lenehan, Patrick, Puranik, Arjun, Seville, Maria T, Speicher, Leigh L., Tulledge-Scheitel, Sidna M., Venkatakrishnan, AJ, Wilker, Caroline G., Badley, Andrew D., Ganesh, Ravindra

Volltext

A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model von Razonable, Raymund R., Aloia, Nicole C. E., Anderson, Ryan J., Anil, Gokhan, Amdt, Lori L., Amdt, Richard F., Ausman, Sara E., Bell, Sarah J., Bierle, Dennis M., Billings, Marcie L., Bishop, Rachel K., Cramer, Carl H., Culbertson, Tracy L., Dababneh, Ala S., Derr, Amber N., Epps, Kevin, Flaker, Susan M., Ganesh, Ravindra, Gilmer, Mary A., Urena, Eric Gomez, Gulden, Christopher R., Haack, Tamara L., Hanson, Sara N., Herzog, Jenna R., Heyliger, Alexander, Hokanson, Lex D., Hopkins, Laura H., Horecki, Richard J., Krishna, Bipinchandra Hirisave, Huskins, W. Charles, Jackson, Tammy A., Johnson, Ryan R., Jorgenson, Betty, Kudma, Cory, Kennedy, Brian D., Klingspom, Mary K., Kottke, Brian, Larsen, Jennifer J., Lessard, Sarah R., Lutwick, Larry I., Malone, Edward J., Matoush, Jennifer A., Micallef, Ivana N., Moehnke, Darcie E., Mohamed, Muhanad, Ness, Colleena N., Olson, Shelly M., Orenstein, Robert, Palraj, Raj, Patel, Janki, Paulson, Damian J., Phelan, David, Peinovich, Margaret T., Ramsey, Wilford L., Rau-Kane, Taunya J., Reid, Kevin I., Reinschmidt, Karen J., Seville, Maria Teresa, Skold, Erin C., Smith, Jill M., Speicher, Leigh L., Spielman, Laurie A., Springer, Donna J., Sweeten, Perry W., Tempelis, Jennifer M., Tulledge-Scheitel, Sidna, Vergidis, Paschalis, Whipple, Daniel C., Wilker, Caroline G., Borgen, Molly J. Destro

Volltext

Sulfur dioxide emissions and sectorial contributions to sulfur deposition in Asia von Arndt, Richard L., Carmichael, Gregory R., Streets, David G., Bhatti, Neeloo

Volltext

Curbing the Delta Surge: Clinical Outcomes Check for updates After Treatment With Bamlanivimab-Etesevimab, Casirivimab-Imdevimab, or Sotrovimab for Mild to Moderate Coronavirus Dis... von Clune, Caroline G, O'Horo, John C, Arndt, Richard F, Culbertson, Tracy L, Kennedy, Brian D, Jackson, Tammy A, Tulledge-Scheitel, Sidna M, Challener, Douglas W, Larsen, Jennifer, Arndt, Lori, Hall, Scott T, Sweeten, Perry W, Razonable, Raymund R, Hanson, Sara N, Ganesh, Ravindra, Heyliger, Alexander

Volltext

Curbing the Delta Surge von Razonable, Raymund R., O’Horo, John C., Challener, Douglas W., Arndt, Lori, Arndt, Richard F., Clune, Caroline G., Culbertson, Tracy L., Hall, Scott T., Heyliger, Alexander, Jackson, Tammy A., Kennedy, Brian D., Larsen, Jennifer, Hanson, Sara N., Sweeten, Perry W., Tulledge-Scheitel, Sidna M., Ganesh, Ravindra

Volltext

Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 von Ganesh, Ravindra, Pawlowski, Colin F, O'Horo, John C, Arndt, Lori L, Arndt, Richard F, Bell, Sarah J, Bierle, Dennis M, Borgen, Molly Destro, Hanson, Sara N, Heyliger, Alexander, Larsen, Jennifer J, Lenehan, Patrick J, Orenstein, Robert, Puranik, Arjun, Speicher, Leigh L, Tulledge-Scheitel, Sidna M, Venkatakrishnan, A J, Wilker, Caroline G, Badley, Andrew D, Razonable, Raymund R

Volltext

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-lmdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019 von Anderson, Ryan J, Hall, Scott T, Arndt, Richard F, Sweeten, Perry W, O'Horo, John, Ausman, Sara E, Kennedy, Brian D, Ganesh, Ravindra, Razonable, Raymund R, Heyliger, Alexander, Challener, Douglas W

Volltext

Seasonal source: Receptor relationships in Asia von Arndt, Richard L, Carmichael, Gregory R, Roorda, Jolynne M

Volltext

Energy consumption and acid deposition in Northeast Asia von Streets, D.G, (Argonne National Laboratory, Argonne, IL (USA))Carmichael, G.R, Amann, M, Arndt, R.L

Volltext

Impact of a perioperative pharmacist on completion rates for preoperative antibiotics von Schroeder, Robert, Arndt, Richard, Matthews, Courtney, Pierce, Benjamin, Normand, Sarah, Dierkhising, Ross, Sands, Cortney

Volltext